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AHN 086, an isothiocyanato derivative of Ro 5-4864 (4'-chlorodiazepam), inhibits radioligand binding to peripheral 
benzodiazepine receptors with characteristics of an irreversible (acylating) ligand. We now report hat pH]AHN 086 la- 
bels a ~ 30 kDa protein in the rat pineal gland determined by both SDS-polyacrylamide gelelectrophoresis and gel filtra- 
tion high-performance liquid chromatography of digitonin-solubilized membranes. Specific incorporation of pH]AHN 
086 into this protein was inhibited by preincubating membranes with excess AHN 086. Moreover, significant specific 
binding of [3H]AHN 086 was not observed in either bovine pineal gland (which does not possess high-affinity binding 
sites for Ro 5-4864) or ovalbumin. These findings suggest hat the ~30 kDa protein labeled by pH]AHN 086 in rat 
pineal gland is associated with peripheral benzodiazepine receptors in this tissue. 
Pineal gland; Peripheral benzodiazepine receptor; Radioligand-receptor binding inhibitor; AHN 086, [all]- 
1. INTRODUCTION 
There is unequivocal evidence that the principal 
psychopharmacological effects of benzodiazepine 
(BZ) agonists are mediated through specific recep- 
tors in the central nervous ystem [1,2]. During the 
past decade, the biochemical and molecular 
properties of BZ receptors located in tissues deriv- 
ed from the neural crest have been well described 
[3-5]. In comparison, much less is known about 
the function and molecular organization of 
recognition sites for BZ receptors found outside 
the central nervous ystem (termed peripheral ben- 
zodiazepine receptors; PBR). While PBR was ini- 
tially characterized in peripheral tissues [6] and 
transformed cell lines of neural origin [7] using 
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[3H]diazepam (which also binds to BZ receptors), 
it is now evident hat BZ receptors and PBR have 
distinct subcellular distributions [8,9], apparent 
molecular masses [10-12] and pharmacological 
specificities [6,7,13-16]. 
Recently, we reported [17,18] that AHN 086 
(1-(2-isothiocyanatoethyl-7-chloro-l,3-dihydro-5- 
(4-chlorophenyt)-2H-1,4-benzodiazepine-2-one hy- 
drochloride), an isothiocyanato derivative of Ro 
5-4864 (4'-chlorodiazepam, the prototype PBR 
ligand) inhibited radioligand binding to PBR in rat 
renal membranes with the characteristics of an ir- 
reversible ligand. In contrast, AHN 086 did not af- 
fect radioligand binding to central BZ receptors 
[18]. Here, we used a radioactive form of AHN 
086 to label irreversibly PBR in rat pineal gland, 
which has been reported to possess a high density 
of these sites [13,19]. We now report that 
[3H]AHN 086 specifically labels a ~-30 kDa pro- 
tein with properties characteristic of PBR. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
1989 Federation of European Biochemical Societies 263 
Volume 244, number 2 FEBS LETTERS February 1989 
Table 1 
Incorporation of [‘H]AHN 086 (pmol/mg protein) 
Tissue Total Nonspecific Specific 
Rat pineal 15.8 9.5 6.3 
Bovine pineal 11.6 10.1 1.5 
Ovalbumin 0.17 0.17 - 
Specificity of [‘H]AHN 086: Samples were prepared as 
described in section 2. Nonspecific incorporation was measured 
by preincubating samples with AHN 086 (1OpM) for 30 min 
prior to the addition of 20 nM [‘H]AHN 086. The amount of 
radioligand specifically incorporated into PBR was defined as 
the difference observed in the presence and absence of AHN 
086 (10 pM). Protein quantities for rat and bovine pineal and 
ovalbumin were 153 pg protein/ml, 44Opg protein/mg and 
2 mg protein/ml, respectively. Rat and bovine pineal data are 
mean pmol/mg protein of two separate xperiments. Analysis 
using ovalbumin was based on one determination as a control 
2. MATERIALS AND METHODS 2.3. Gel-filtration chromatography 
2.1. Tissue preparation 
Adult, male Sprague-Dawley rats (Zivic-Miller, Allison Park, 
PA) were housed in a 12 h light/dark cycle with free access to 
Pineal membranes prelabeled with [‘H]AHN 086 were cen- 
trifuged at 230&l x g (4°C) and the pellet resuspended 
(Brinkman Polytron) in 100 vols of 50 mM Tris-HCl (pH 7.4) 
buffer containing 1% digitonin. ‘The membrane suspensions 
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laboratory chow and water. Animals were killed by decapita- 
tion, the pineal glands were removed, frozen rapidly on solid 
CO* and then stored at - 70°C. Tissues were homogenized in 
100 vols ice-cold 0.32 M sucrose using a motor-driven Teflon 
pestle and glass homogenizer (lo-12 passes). The homogenate 
was centrifuged at 1000 x g for 10 min (4°C). The resulting 
pellet (Pi) was discarded and the supernatant centrifuged at 
23 000 x g for 20 min at 4°C. The enriched mitochondrial pellet 
(Pz) was resuspended with a Brinkman Polytron (setting 5, 5 s) 
in 100 vols of 50 mM KHzP04/KzHP04 buffer (pH 7.0). 
Frozen bovine pineal glands were processed in an identical 
manner. 
2.2. Tissue labeling with [3H]AHN 086 
Homogenates were incubated in buffer with 20 nM [‘H]AHN 
086 for 30 min at 4°C. In some experiments, tissues were prein- 
cubated for 30 min with 10 PM AHN 086 prior to addition of 
the radiolabeled compounds. The radioactivity incorporated in 
an aliquot of this tissue was determined by liquid scintillation 
counting (Beckman LS 5801). Protein content was routinely 
determined according to Bradford 1201. 
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Fig. 1. (A) BioSil TSK-250 chromatography of [3H]AHN-labeled, digitonin-solubilized membranes. Disrupted Pz membrane fractions 
from rat pineal were incubated with [‘H]AHN 086 (20 nM) or preincubated with AHN 086 (10 CM) prior to incubation with radiolabel 
as described in section 2. Aliquots (200~1) were applied to a Bio-Rad BioSil TSK-250 column at a flow rate of 0.5 ml/min and 
radioactivity monitored directly from the column using a Flo-One Beta Radioactive flow detector. Abscissa: analog tritium signal. 
Molecular mass markers (kDa) monitored at Azsa: (a) void volume (blue dextran) and thyroglobulin, 690; (b) ferritin, 440; (c) IgG, 
160; (d) aldolase, 158; (e) ovalbumin (Bio-Rad), 44; (f) ovalbumin (Pharmacia), 43; (g) myoglobin, 17.5; (h) cyanocobalamin, 1.4. 
The center of the peak of radioactivity (top line) corresponds to 27 kDa (arrow). Preincubating tissue with AHN 086 eliminated the 
18.2 min peak (lower trace). (B) Chromatogram representing [3H]AHN 086 incorporation into bovine pineal gland. Tissues were 
prepared and analyzed in the same fashion’as in (A). No analog tritium signal was observed in the same 27 kDa region as in the rat 
pineal. Data are representative of at least three separate determinations. Equal amounts of radioactivity were analyzed in both rat and 
bovine pineal gland. 
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were maintained at 4°C for 20 min. Samples were then cen- 
trifuged at 100000 x gin a Beckman Airfuge. Aliquots (200 ~1) 
of supernatant were applied to a BioSil TSK-250 column and 
eluted at a flow rate of 0.5 ml/min with 20 mM NasHPOd buf- 
fer (pH 6.8) containing 0.5% octyl-fi-D-glucopyranoside and 
50 mM NazSOa. Radioactivity was monitored as an analog 
signal using a Radiomatic Instruments Flo-One Beta Radioac- 
tive flow detector. In some experiments, 1ml aliquots were col- 
lected and the radioactivity monitored by liquid scintillation 
counting. The column was calibrated with molecular mass stan- 
dards (Bio-Rad, Pharmacia and Sigma; range, l-690 kDa). 
2.4. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Frozen membrane pellets labeled with [3H]AHN 086 were 
thawed and solubilized in 10070 (w/v) SDS with 100 mM Tris- 
HCl (ph 7.4), 5 mM ,&mercaptoethanol, 0.1 g/ml sucrose and 
0.02 mg/ml bromophenol blue tracking dye [21-231. Samples 
were placed in boiling water for 5 min and 4.0~~1 aliquots 
(I 100 fig protein/well) were loaded on 1.4 mm thick loo/, 
polyacrylamide slab gels [24]. The gels were electrophoresed us- 
ing a running buffer (0.1% SDS, 25 mM Tris and 190 mM 
glycine) with a potential of 80 V applied for the first 1.5 h and 
a 180 V for the remaining 2.5 h [22,23]. The gels were vacuum 
dried for 2 h and exposed to Kodak X-Omat R film [25] for 3 
weeks. The apparent molecular masses of the radioactive bands 
were determined by comparing their migration with standard 
protein markers (Rainbow Markers, Amersham, Arlington 
Heights, IL) of 14-200 kDa. 
2.5. Materials 
AHN 086 was prepared as described [17]. [3H]AHN 086 
(spec. act. 45 Ci/mmol) was synthesized from N- 
desmethyl-4’-chlorodiazepam by DuPont-NEN, Boston, MA. 
All other materials were obtained from standard commercial 
sources. 
3. RESULTS 
While [3H]AHN 086 was incorporated into rat 
or bovine pineal proteins as well as ovalbumin, 
significant specific incorporation was detected on- 
ly in rat pineal (table 1). Gel-filtration 
chromatography of digitonin-solubilized mem- 
branes from rat pineal revealed a single major peak 
of radioactivity with a retention time of 18.2 + 
0.1 min corresponding to 27 + 2.1 kDa (fig.lA). 
This peak was reduced by preincubation with 
AHN 086 (10 PM). A corresponding peak was not 
observed when an equal amount of radioactivity 
from bovine pineal was applied to this column 
(fig. 1B). Collection and scintillation counting of 
1 ml fractions of [3H]AHN 086 labeled rat pineal 
membranes with and without preincubation in the 
presence of AHN 086 revealed a 47% reduction in 
radioactivity corresponding to the same retention 
time as the 27 kDa peak. In contrast, preincuba- 
tion of bovine pineal with AHN 086 did not result 
in a decrease in radioactivity at the corresponding 
retention time (not shown). A major band cor- 
responding to a 30.6 kDa protein by [3H]AHN 086 
was also observed using SDS-PAGE (fig.2). Prein- 
cubation of rat pineal membranes with 10 PM 
AHN 086 reduced incorporation of [3H]AHN 086 
into the primary protein band (not shown). Minor 
protein bands were present slightly above 
(31 .l kDa) and below (30.1 kDa) the primary 
30.6 kDa protein band (fig.1). 
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Fig.2. SDS-PAGE of [‘HIAHN 086 (20 nM) binding to rat 
pineal. P2 fractions of rat pineal were incubated with [3H]AHN 
086, solubilized, and SDS-PAGE performed as described in 
section 2. (A) Coomassie blue stain of proteins of rat pineal 
membranes. (B) Fluorography of irreversible [3H]AHN 086 
binding to rat pineal membranes identifies a 130 kDa protein 
band. Rainbow markers (14-200 kDa) were included to 
calibrate the gel with known molecular masses. Densitometric 
scan of the fluorogram indicates relative densities of the bands 
found in the ~30 kDa range. The results are representative of 
at least three separate determinations using identical 
procedures. 
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4. DISCUSSION 
AHN 086 is an isothiocyanato derivative of Ro 
5-4864, the prototype ligand used to characterize 
PBR [ 14,26-281. This compound was shown to in- 
hibit potently and specifically radioligand binding 
to PBR with characteristics of an irreversible 
(acylating) ligand [17,18]. The synthesis of 
[3H]AHN 086 afforded a high-affinity, selective 
radioligand for characterization of PBR. 
Rat pineal gland was selected for study, since it 
has been shown to possess a high density of PBR 
[ 13,191. In preliminary experiments, preincubation 
of rat pineal membranes with Ro 5-4864 (10 ,uM) 
or PK 11195 (10 PM) did not significantly reduce 
incorporation of [3H]AHN 086 (not shown). These 
observations are consistent with previous findings 
[ 181 that under identical incubation conditions, 
neither PK 11195 nor Ro 5-4864 could block the ir- 
reversible inhibition of radioligand binding to PBR 
produced by AHN 086 [18]. However, prelabeling 
pineal membranes with AHN 086 (10 PM) reduced 
the binding of [3H]AHN 086 by 37-49% (table 1). 
Several ines of evidence suggest hat this reduction 
in radioligand binding represents pecific binding 
to PBR. A similar effect of AHN 086 was observed 
in neither [3H]AHN 086-labeled bovine pineal 
(which lacks high-affinity binding sites for Ro 
5-4864) [29] nor ovalbumin (table 1). Moreover, 
this concentration of AHN 086 has been shown to 
block reversible radioligand binding to PBR [ 181. 
Gel-filtration chromatography of rat pineal ex- 
tracts prelabeled with [3H]AHN 086 revealed a ma- 
jor peak of radioactivity with a retention time of 
18.2 min, corresponding to 27 kDa. Preincubation 
of membranes with AHN 086 reduced specific 
binding which suggests that this peak corresponds 
to material specifically labeled by [3H]AHN 086. 
In addition, application of equal amounts of 
radioactivity from bovine pineal did not yield a 
peak of radioactivity with a parallel retention time 
(fig.lB). SDS-PAGE also demonstrated a major 
band of radioactive material of ~30 kDa (fig.2) 
which was reduced in membranes prelabeled with 
cold AHN 086 (not shown). This finding further 
supports the suggestion that the protein labeled by 
[3H]AHN 086 is associated with PBR in rat pineal. 
The apparent molecular mass of PBR in rat 
pineal obtained with [3H]AHN 086 is in good 
agreement with both the target size of PBR (34 + 
266 
4 kDa) in rat estimated by radiation inactivation 
using [3H]diazepam [lo] and by photoaffinity 
labeling with [3H]flunitrazepam [30]. In this latter 
study, proteins of =30 and =35 kDa were photoaf- 
finity labeled, with the larger protein exhibiting 
characteristics of a voltage-dependent anion chan- 
nel (VDAC) protein [30]. In contrast, several 
studies using [3H]PK 14105 (a nitrophenyl 
derivative of PK 11195) to photoaffinity label PBR 
from a number of tissues observed 17-18.5 kDa 
proteins [31-331 with SDS-PAGE. 
These differences in apparent molecular mass 
could be attributed to the methodologies used to 
identify and label PBR. Alternatively, iso- 
quinolinecarboxamides (such as PK 11195) and 
1,CBZs may label distinct PBR proteins. Thus, 
while B,, estimates of PBR using t3H]PK 11195 
and [3H]Ro 5-4864 are in good agreement in many 
rodent tissues [9,18,29], there does not appear to 
be a high-affinity binding site for PBR ligands with 
a 1,4-BZ structure in other mammalian species in- 
cluding cow and man [29,34]. This hypothesis is 
further supported by gel-filtration chromatog- 
raphy of digitonin-solubilized rat or bovine 
adrenal glands, where [3H]PK 14105 labeled a pro- 
tein of 215 kDa [l 11, a value in good agreement 
with that found in rat renal membranes olubilized 
with Triton X-100 and detected with [3H]Ro 
5-4864 [35]. While it is possible that this apparent 
molecular mass reflects detergent molecules bound 
to protein [11,31], these findings may indicate a 
multimeric arrangement of 18 and 30 kDa proteins 
in rodent tissues. Future studies with molecules 
capable of covalent attachment to PBR should 
prove valuable in determining their molecular ar- 
rangement, structure and function. 
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